drugset / Trial / NCT01172236
Supplementation With Lactoferrin in Preterm Newborns
NaSingle-groupOpen-labelTreatment
Summary
The main objective of the study is to evaluate the antioxidant effect of lactoferrin and its ability to reduce free radicals related diseases in the newborn. This evaluation will be done through the assessment of neuro-developmental follow-up. The secondary objective is to identify a panel of markers for assessing oxidative stress and for a correlation with the lactoferrin antioxidant effect.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactoferrin | Protein / enzyme biologic | 100 mg | — |